The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What is there to know about the EBMT GoCART coalition?

During the 3rd European CAR T-cell Meeting, the Multiple Myeloma Hub spoke to Sofie Rosanne Terwel, EBMT GoCART, Leiden, NL. We asked, What is there to know about the EBMT GoCART coalition?

Sofie Terwel gives a brief overview of the EBMT GoCART coalition, a multi-stakeholder initiative for cellular therapy, and includes information regarding the structure and aims of the organization. She also describes the six work packages that the coalition produces.


Share:

Your opinion matters

Test your knowledge! CAR-T products are more advanced than bsAbs/BiTEs in MM, and BCMA is the most popular target antigen
11 votes - 2 days left ...

Newsletter

Subscribe to get the best content related to multiple myeloma delivered to your inbox